Cargando…
Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation
Lung transplantation has become an important therapeutic option for patients with end-stage organ dysfunction; however, its clinical usefulness has been limited by the relatively early onset of chronic allograft dysfunction and progressive clinical decline. Obliterative bronchiolitis is characterize...
Autores principales: | Lin, Christine M., Zamora, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100813/ https://www.ncbi.nlm.nih.gov/pubmed/32226712 http://dx.doi.org/10.1007/s40472-014-0030-9 |
Ejemplares similares
-
The New Direct Antiviral Agents and Hepatitis C in Thoracic Transplantation: Impact on Donors and Recipients
por: Gottlieb, Robert L., et al.
Publicado: (2018) -
Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient
por: Baran, David A.
Publicado: (2017) -
Heart Retransplantation: Candidacy, Outcomes, and Management
por: Barghash, Maya H., et al.
Publicado: (2019) -
Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation
por: Müller, Catharina, et al.
Publicado: (2017) -
A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation
por: Corris, Paul A, et al.
Publicado: (2015)